The Company’s total debt as of December 31, 2024 was $325.1 million as compared to $311.4 million as of fiscal year end 2023. The Company’s net debt (total debt less cash and cash equivalents), a ...

Total Revenues increased 30.8% for the quarter over the prior year period to $51.7 million –– Total Written Premium increased 20.0% for the ...

Turpaz sales in the fourth quarter jumped 65% to a record $55 million; adj. EBITDA, which is among the industry leaders, rose to 23% of sales in the fourth quarter, reflecting a 66.7% increase ...

Hudson Global, Inc. (NASDAQ: HSON) Q4 2024 Earnings Call Transcript March 14, 2025 Hudson Global, Inc. beats earnings ...

Q4 2024 Earnings Call Transcript March 5, 2025 Riskified Ltd. misses on earnings expectations. Reported EPS is $0.06 EPS, ...

LOUISVILLE, Colo., March 03, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced its financial and operating results for the fourth quarter ...

The company ended 2024 with fourth-quarter revenue up 4.8% to $1.11 billion, while adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) spiked 18.2% to $246.2 million.

The latest episode of Shark Tank India Season 4 saw a heated pitch from the founders of Trajectory, seeking Rs 1 crore for 2% equity. Despite Anupam Mittal's intense critique and branding concerns, ...

And the segment’s adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) surged 78% to $950 million, beating forecasts. Theatrical revenue decreased 9% on fewer releases.

WBD previously said it was targeting $1 billion or more in DTC earnings before interest, taxes, depreciation and amortization (EBITDA) in 2025. Zaslav, however, more recently told Wall Street that ...